Concord Drugs standalone net profit rises 60.61% in the March 2016 quarter

Sales rise 30.22% to Rs 13.96 crore

Net profit of Concord Drugs rose 60.61% to Rs 0.53 crore in the quarter ended March 2016 as against Rs 0.33 crore during the previous quarter ended March 2015. Sales rose 30.22% to Rs 13.96 crore in the quarter ended March 2016 as against Rs 10.72 crore during the previous quarter ended March 2015.

For the full year,net profit rose 198.57% to Rs 2.09 crore in the year ended March 2016 as against Rs 0.70 crore during the previous year ended March 2015. Sales rose 26.64% to Rs 50.68 crore in the year ended March 2016 as against Rs 40.02 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.Sales13.9610.72 30 50.6840.02 27 OPM %11.3929.20 -16.6518.49 - PBDT1.022.20 -54 5.874.68 25 PBT0.390.58 -33 2.961.05 182 NP0.530.33 61 2.090.70 199

Powered by Capital Market - Live News